As per the global ready-to-use therapeutic market analysis report by FMI, the market valuation is expected to be around US$ 429 million in 2023. By the end of this forecast period, the global sales of ready-to-use therapeutic food are anticipated by FMI to generate revenues of around US$ 743.4 million.
Undernutrition is responsible for around 45% of fatalities among the Under 5 children group as a result of rising rates of malnutrition throughout the world. The rising concern of international communities to combat the menace by available options is what boosts the demand for ready-to-use therapeutic food internationally. Earlier, the American Journal of Clinical Nutrition published that 96% of kids who received RUTF treatment were visibly nourished within a year.
To Get a Sample Copy of the Report visit@ https://www.futuremarketinsights.com/reports/sample/rep-gb-12642
Interestingly enough, the impact of the Covid-19 pandemic was drastic across the developing and underdeveloped worlds that benefitted the market after a short while. It was apprehended that severely malnourished children were at a dangerously high risk of contracting the novel coronavirus due to weakened immunity. So considerable efforts were made for the provisioning of ready-to-eat therapeutic foods boosting its sales in the global market.
However, higher costs and the absence of sufficient market channels are projected to impede the growth of RTE therapeutic food products throughout the forecast period. Many producers of RTD therapeutic products do not adhere to WHO’s food product preparation standards, resulting in microbial contamination.
Key Takeaways from the Ready-to-use Therapeutic Food Market Study Report
- Based on market survey reports, the sales of ready-to-use therapeutic foods were dominated by the United States, with a revenue share of 23.5% in 2022.
- Likewise, Germany is a leading contributor of RTD therapeutic products in the UNICEF programs and held a market share of 14.5% in 2022.
- Contrastingly, Asia Pacific countries are performing well these days and have increased their ready-to-eat therapeutic food production capacity to compete globally. While the market for this commodity in China is projected to grow at 4.5% through 2033 India is expected to advance at a 6.5% growth rate.
- Increasing sales of the drinkable therapeutic food segment is likely to fuel the expansion of the ready-to-use therapeutic food industry through the forecast years. Over the forecast years, a staggering double-digit CAGR is predicted for the drinkable therapeutic foods segment.
Didn’t find the data you are looking for?
Our experts provide you customized reports! https://www.futuremarketinsights.com/customization-available/rep-gb-12642
Competitive Landscape for the Ready-to-use Therapeutic Food Market Players
Nuflower Foods, GC Rieber Compact AS, Valid Nutrition, InnoFaso Corp., Edesia Inc., Nutrivita Foods Ltd., Diva Nutritional Products, Insta Products Ltd., Mana Nutritive Aid Product Inc., Meds & Food for Kids Inc., Samil Industrial Co., Tabatchnick Fine Foods Inc., Amul India Inc., Hilina Enriched Foods PLC, and Société de Transformation Alimentaire among others are some key players in the global ready-to-use therapeutic food market.
Throughout the forecast period, the overall market is expected to remain consolidated due to the presence of a few key players globally. Market growth is anticipated to accelerate due to an increase in collaborations in the regional markets for the production of RUTF at a higher quantity.
For example, the Federal Government of Nigeria signed an MOU with UNICEF in May 2018 to acquire and supply RUTF in the country in huge quantities. The cooperation aimed to act as a parallel contribution to the acquisition and delivery of the goods throughout the state’s six affected zones.
Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-12642
Industry Key Segment
By Type:
- Solid Therapeutic Food
- Power or Blend Form
- Biscuits or Bar Form
- Paste Therapeutic Food
- Drinkable Therapeutic Food
- Other Ready-to-use Therapeutic Foods
By End User:
- United National International Children’s Emergency Fund (UNICEF)
- World Food Program (WFP)
- Government Organizations
- Non-governmental Organizations (NGOs)
- Other End Users
By Region:
- North America (United States, & Canada)
- Latin America (Brazil, Mexico & Rest of Latin America)
- Europe (France, Germany, Spain, United Kingdom Italy, BENELUX, Nordics, Russia, Poland & Rest of Europe)
- Asia Pacific (China, India, Japan, ASEAN, Australia & New Zealand, and the Rest of APAC)
- The Middle East & Africa (GCC, North Africa, Tanzania, Ethiopia, Nigeria, Malawi, Kenya, South Africa & Rest of MEA)
About FMI
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization, and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel, and End Use over the next 10 years.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse Other Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs